EFFECTOR THERAPEUTICS INC - *W EXP 12/31/202 (EFTRW)

CUSIP: 28202V116

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / *W EXP 12/31/202
Total 13F shares
3,431,914
Share change
+101,260
Total reported value
$1,312,299
Price per share
$0.41
Number of holders
17
Value change
-$3,079
Number of buys
4
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 28202V116?
CUSIP 28202V116 identifies EFTRW - EFFECTOR THERAPEUTICS INC - *W EXP 12/31/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EFFECTOR THERAPEUTICS INC - *W EXP 12/31/202 (EFTRW) as of Q1 2022

As of 31 Mar 2022, EFFECTOR THERAPEUTICS INC - *W EXP 12/31/202 (EFTRW) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,431,914 shares. The largest 10 holders included ARISTEIA CAPITAL LLC, GOLDMAN SACHS GROUP INC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, WHITEBOX ADVISORS LLC, MMCAP International Inc. SPC, PURA VIDA INVESTMENTS, LLC, CVI Holdings, LLC, Parallel Advisors, LLC, III Capital Management, and EQUITEC PROPRIETARY MARKETS, LLC. This page lists 17 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.